- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 277/36 - Atomes de soufre
Détention brevets de la classe C07D 277/36
Brevets de cette classe: 260
Historique des publications depuis 10 ans
16
|
15
|
11
|
20
|
21
|
13
|
17
|
19
|
9
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Novartis AG | 10744 |
16 |
Corteva Agriscience LLC | 2682 |
9 |
Sumitomo Chemical Company, Limited | 9043 |
6 |
ADAMA Makhteshim Ltd. | 511 |
6 |
Bionevia Pharmaceuticals, Inc. | 12 |
6 |
The Institute of Cancer Research: Royal Cancer Hospital | 183 |
6 |
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin | 165 |
6 |
The University of Queensland | 661 |
6 |
Ohio University | 366 |
5 |
University of Southern California | 2110 |
4 |
The Board of Regents of the University of Texas System | 2210 |
4 |
Paris Sciences et Lettres - Quartier Latin | 212 |
4 |
Immunesensor Therapeutics, Inc. | 35 |
4 |
Orsobio, Inc. | 13 |
4 |
Syngenta Crop Protection AG | 6074 |
3 |
Centre National de La Recherche Scientifique | 10464 |
3 |
The General Hospital Corporation | 4740 |
3 |
Astellas Pharma Inc. | 1087 |
3 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | 58 |
3 |
The University of British Columbia | 1495 |
3 |
Autres propriétaires | 156 |